The store will not work correctly when cookies are disabled.
(E)-3-(4-(dimethylamino)phenyl)-1-(5-isopropylpyrazin-2-yl)prop-2-en-1-one
ID: ALA2288601
PubChem CID: 76331125
Max Phase: Preclinical
Molecular Formula: C18H21N3O
Molecular Weight: 295.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)c1cnc(C(=O)/C=C/c2ccc(N(C)C)cc2)cn1
Standard InChI: InChI=1S/C18H21N3O/c1-13(2)16-11-20-17(12-19-16)18(22)10-7-14-5-8-15(9-6-14)21(3)4/h5-13H,1-4H3/b10-7+
Standard InChI Key: JSSKMOPDEPGNOS-JXMROGBWSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
10.4157 -15.3698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4146 -16.1893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1226 -16.5983 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8323 -16.1888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8294 -15.3662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1208 -14.9609 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.5356 -14.9549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2448 -15.3608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5325 -14.1377 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9510 -14.9496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6603 -15.3555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6602 -16.1716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3686 -16.5774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0758 -16.1661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0701 -15.3447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3611 -14.9425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7065 -16.5973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9991 -16.1882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7059 -17.4145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7856 -16.5711 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7897 -17.3883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4912 -16.1589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
2 17 1 0
17 18 1 0
17 19 1 0
14 20 1 0
20 21 1 0
20 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 295.39 | Molecular Weight (Monoisotopic): 295.1685 | AlogP: 3.56 | #Rotatable Bonds: 5 |
Polar Surface Area: 46.09 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.73 | CX LogP: 3.32 | CX LogD: 3.32 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.62 | Np Likeness Score: -0.53 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |